Answer
The Rosemont Pharmaceuticals Limited product, bumetanide 0.2 mg/ml oral solution, should not be used during pregnancy unless clearly necessary and only when the potential benefit justifies the potential risk to the foetus, as adequate pregnancy data are lacking.
Sources for this answer
- Bumetanide 0.2 mg/ml Oral SolutionRosemont Pharmaceuticals Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked